{
    "title": "WHO 'strongly recommends' Pfizer's Covid pill",
    "url": "https://www.dailymail.co.uk/wires/afp/article-10741507/WHO-strongly-recommends-Pfizers-Covid-pill.html",
    "date": "2022-04-21",
    "keywords": [
        "paxlovid",
        "risk",
        "pill",
        "disease",
        "whos",
        "pfizer",
        "recommendation",
        "drug",
        "remdesivir",
        "percent",
        "world",
        "hospitalisation",
        "access",
        "treatment",
        "course",
        "health",
        "organization",
        "agency",
        "inequality",
        "end",
        "combination",
        "nirmatrelvir",
        "ritonavir",
        "choice",
        "journal",
        "firm",
        "gilead",
        "molnupiravir",
        "admission",
        "difference",
        "mortality",
        "discontinuation",
        "age",
        "benefit",
        "opinion",
        "lack",
        "medicine",
        "doctor",
        "step",
        "pandemic",
        "home",
        "onset",
        "cost",
        "pricing",
        "lisa",
        "advisor",
        "radio",
        "station",
        "source",
        "price",
        "income",
        "country",
        "meanwhile",
        "hedman",
        "india",
        "sell",
        "question",
        "mark",
        "virus",
        "resistance",
        "month",
        "ceo",
        "albert",
        "bourla",
        "future",
        "booster",
        "fire",
        "vaccine",
        "scheme"
    ],
    "category": [
        "wires",
        "afp"
    ]
}